首页> 外文期刊>Physiological Reports >Effects of insulin and the glucagon?¢????like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice
【24h】

Effects of insulin and the glucagon?¢????like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice

机译:胰岛素和胰高血糖素样肽1受体激动剂利拉鲁肽对db / db小鼠肾脏蛋白质组的影响

获取原文
获取外文期刊封面目录资料

摘要

Diabetes mellitus (DM) is a worldwide disease that affects 9% of the adult world population and type 2 DM accounts for 90% of those. A common consequence of DM is kidney complications, which could lead to kidney failure. We studied the potential effects of treatment with insulin and the glucagon?¢????like peptide 1 receptor (GLP?¢????1R) agonist liraglutide on the diabetic kidney proteome through the use of the db/db mouse model system and mass spectrometry (MS). Multivariate analyses revealed distinct effects of insulin and liraglutide on the db/db kidney proteome, which was seen on the protein levels of, for example, pterin?¢????4 ???± ?¢????carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor?¢????1 ???± (PCBD1), neural precursor cell expressed developmentally down?¢????regulated?¢????8 (NEDD8), transcription elongation factor?¢????B polypeptide?¢????1 (ELOC) and hepcidin (HEPC). Furthermore, the separation of the insulin, liraglutide and vehicle db/db mouse groups in multivariate analyses was not mainly related to the albumin excretion rate (AER) or the level of glycated hemoglobin A 1c (HbA 1c %) in the mice. In summary, we show that insulin and liraglutide give rise to separate protein profiles in the db/db mouse kidney.
机译:糖尿病(DM)是一种世界性疾病,影响了9%的成年人,而2型DM则占90%。糖尿病的常见后果是肾脏并发症,这可能导致肾脏衰竭。我们通过使用db / db小鼠模型系统研究了胰岛素和胰高血糖素样肽1受体(GLPβ1R)激动剂利拉鲁肽治疗对糖尿病肾脏蛋白质组的潜在影响。和质谱(MS)。多变量分析揭示了胰岛素和利拉鲁肽对db / db肾脏蛋白质组的明显影响,这在例如蝶呤β4β±甲醇胺脱水酶/肝细胞核因子的二聚化辅助因子1(PCBD1),神经前体细胞发育下降,表达受调控(8)(NEDD8),转录延伸因子。 B多肽β1(ELOC)和铁调素(HEPC)。此外,在多变量分析中,胰岛素,利拉鲁肽和媒介物db / db小鼠组的分离与小鼠中的白蛋白排泄率(AER)或糖化血红蛋白A 1c(HbA 1c%)的水平无关。总而言之,我们显示胰岛素和利拉鲁肽在db / db小鼠肾脏中产生单独的蛋白质谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号